Aroa Biosurgery Ltd (ARX) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.045x

Based on the latest financial reports, Aroa Biosurgery Ltd (ARX) has a cash flow conversion efficiency ratio of 0.045x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$3.64 Million ≈ $2.58 Million USD) by net assets (AU$80.93 Million ≈ $57.26 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Aroa Biosurgery Ltd - Cash Flow Conversion Efficiency Trend (2014–2025)

This chart illustrates how Aroa Biosurgery Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read ARX current and long-term liabilities for a breakdown of total debt and financial obligations.

Aroa Biosurgery Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Aroa Biosurgery Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
COPRD NYSE MKT:COPRD	0.022x
Atlantic Lithium Ltd AU:A11	-0.046x
SKP Resources Bhd KLSE:7155	0.062x
Clavister Holding AB (publ.) ST:CLAV	-0.204x
Boab Metals Ltd AU:BML	-0.108x
Condor Energies Inc. TO:CDR	0.162x
Alam Sutera Realty Tbk JK:ASRI	0.058x
Kotra Industries Bhd KLSE:0002	0.017x

Annual Cash Flow Conversion Efficiency for Aroa Biosurgery Ltd (2014–2025)

The table below shows the annual cash flow conversion efficiency of Aroa Biosurgery Ltd from 2014 to 2025. For the full company profile with market capitalisation and key ratios, see Aroa Biosurgery Ltd (ARX) market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-03-31	AU$84.59 Million ≈ $59.85 Million	AU$-2.33 Million ≈ $-1.65 Million	-0.028x	+64.51%
2024-03-31	AU$87.09 Million ≈ $61.62 Million	AU$-6.76 Million ≈ $-4.79 Million	-0.078x	-109.81%
2023-03-31	AU$95.38 Million ≈ $67.49 Million	AU$-3.53 Million ≈ $-2.50 Million	-0.037x	+67.71%
2022-03-31	AU$93.40 Million ≈ $66.09 Million	AU$-10.71 Million ≈ $-7.58 Million	-0.115x	-22.95%
2021-03-31	AU$53.69 Million ≈ $37.99 Million	AU$-5.01 Million ≈ $-3.54 Million	-0.093x	-471.64%
2020-03-31	AU$62.86 Million ≈ $44.48 Million	AU$1.58 Million ≈ $1.12 Million	0.025x	+4523.65%
2019-03-31	AU$11.52 Million ≈ $8.15 Million	AU$-6.54K ≈ $-4.62K	-0.001x	+99.96%
2018-03-31	AU$1.77 Million ≈ $1.25 Million	AU$-2.80 Million ≈ $-1.98 Million	-1.586x	-1251.70%
2017-03-31	AU$6.28 Million ≈ $4.44 Million	AU$-737.06K ≈ $-521.52K	-0.117x	-70.03%
2016-03-31	AU$5.91 Million ≈ $4.18 Million	AU$-408.04K ≈ $-288.71K	-0.069x	+64.65%
2015-03-31	AU$6.92 Million ≈ $4.90 Million	AU$-1.35 Million ≈ $-956.64K	-0.195x	-8.88%
2014-03-31	AU$7.58 Million ≈ $5.36 Million	AU$-1.36 Million ≈ $-961.75K	-0.179x	--

About Aroa Biosurgery Ltd

AU:ARX Australia Medical Devices

Market Cap

$150.91 Million

AU$213.27 Million AUD

Market Cap Rank

#17617 Global

#525 in Australia

Share Price

AU$0.62

Change (1 day)

-3.91%

52-Week Range

AU$0.43 - AU$0.80

All Time High

AU$1.54